Literature DB >> 36168057

The endoplasmic reticulum stress response in prostate cancer.

Claire M de la Calle1, Kevin Shee1, Heiko Yang1, Peter E Lonergan1,2,3, Hao G Nguyen4.   

Abstract

In order to proliferate in unfavourable conditions, cancer cells can take advantage of the naturally occurring endoplasmic reticulum-associated unfolded protein response (UPR) via three highly conserved signalling arms: IRE1α, PERK and ATF6. All three arms of the UPR have key roles in every step of tumour progression: from cancer initiation to tumour growth, invasion, metastasis and resistance to therapy. At present, no cure for metastatic prostate cancer exists, as targeting the androgen receptor eventually results in treatment resistance. New research has uncovered an important role for the UPR in prostate cancer tumorigenesis and crosstalk between the UPR and androgen receptor signalling pathways. With an improved understanding of the mechanisms by which cancer cells exploit the endoplasmic reticulum stress response, targetable points of vulnerability can be uncovered.
© 2022. Springer Nature Limited.

Entities:  

Year:  2022        PMID: 36168057     DOI: 10.1038/s41585-022-00649-3

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   16.430


  253 in total

Review 1.  Membrane phospholipid synthesis and endoplasmic reticulum function.

Authors:  Paolo Fagone; Suzanne Jackowski
Journal:  J Lipid Res       Date:  2008-10-23       Impact factor: 5.922

Review 2.  Signal integration in the endoplasmic reticulum unfolded protein response.

Authors:  David Ron; Peter Walter
Journal:  Nat Rev Mol Cell Biol       Date:  2007-07       Impact factor: 94.444

Review 3.  Divergent Modulation of Proteostasis in Prostate Cancer.

Authors:  Petek Ballar Kirmizibayrak; Burcu Erbaykent-Tepedelen; Oguz Gozen; Yalcin Erzurumlu
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 4.  The unfolded protein response: controlling cell fate decisions under ER stress and beyond.

Authors:  Claudio Hetz
Journal:  Nat Rev Mol Cell Biol       Date:  2012-01-18       Impact factor: 94.444

5.  Cancer statistics, 2022.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2022-01-12       Impact factor: 508.702

Review 6.  Targeting the Unfolded Protein Response in Hormone-Regulated Cancers.

Authors:  Yang Jin; Fahri Saatcioglu
Journal:  Trends Cancer       Date:  2020-01-16

7.  Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity.

Authors:  Martin Niethammer; Chris C Tang; An Vo; Nha Nguyen; Phoebe Spetsieris; Vijay Dhawan; Yilong Ma; Michael Small; Andrew Feigin; Matthew J During; Michael G Kaplitt; David Eidelberg
Journal:  Sci Transl Med       Date:  2018-11-28       Impact factor: 17.956

Review 8.  The endoplasmic reticulum: structure, function and response to cellular signaling.

Authors:  Dianne S Schwarz; Michael D Blower
Journal:  Cell Mol Life Sci       Date:  2015-10-03       Impact factor: 9.261

Review 9.  Persistent androgen receptor addiction in castration-resistant prostate cancer.

Authors:  Michael T Schweizer; Evan Y Yu
Journal:  J Hematol Oncol       Date:  2015-11-13       Impact factor: 17.388

10.  Particulate Matter Increases the Severity of Bleomycin-Induced Pulmonary Fibrosis through KC-Mediated Neutrophil Chemotaxis.

Authors:  I-Yin Cheng; Chen-Chi Liu; Jiun-Han Lin; Tien-Wei Hsu; Jyuan-Wei Hsu; Anna Fen-Yau Li; Wen-Chao Ho; Shih-Chieh Hung; Han-Shui Hsu
Journal:  Int J Mol Sci       Date:  2019-12-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.